focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

commences trading on the OTCQB Venture Market

12 Aug 2020 14:00

RNS Number : 9551V
Applied Graphene Materials PLC
12 August 2020
 

12 August 2020

Applied Graphene Materials plc

("Applied Graphene Materials", "AGM" or "the Group")

Applied Graphene Materials commences trading on the OTCQB Venture Market in the United States

Applied Graphene Materials (LSE: AGM), the producer of specialty graphene materials, is pleased to announce that the Company's shares will cross-trade publicly on the US OTCQB Venture Market ("OTCQB"), under the ticker APGMF, commencing 12 August 2020.

Trading on the US OTC market will have no impact on existing AGM ordinary shares admitted to trading on the AIM Market of the London Stock Exchange and no new ordinary shares were issued as part of the cross-trade. The Group will continue to rely on the announcements and disclosures it makes to the London Stock Exchange and has no Sarbanes-Oxley or SEC reporting requirements.

The cross-trading facility is provided through OTC Markets Group Inc., located in New York. OTC Markets operates the world's largest electronic interdealer quotation system for US broker dealers and offers multiple media channels to increase the visibility of OTC-listed companies. Independent studies show that trading on the OTC by an international company offers a positive effect on the liquidity of its shares.

Adrian Potts, AGM CEO, commented: 

"AGM is building a strong international commercial profile including in the U.S. where we see significant potential for our product offering, in addition to the recent signing of a distribution agreement with Maroon Group, LLC, and so we are also delighted to be joining the OTCQB Market, with a view to increasing our visibility to the investment community, broadening our shareholder base and improving liquidity."

 

For further information, please contact:

Applied Graphene Materials +44 (0) 1642 438 214

Adrian Potts, Chief Executive Officer

David Blain, Chief Financial Officer

 

Hudson Sandler +44 (0) 207 796 4133

Charlie Jack / Emily Dillon

 

N+1 Singer +44 (0) 207 496 3000

Peter Steel / Amanda Gray

 

Notes to Editors

Applied Graphene Materials works in partnership with its customers using its knowledge and expertise to provide bespoke graphene dispersions and formats to deliver enhancements and benefits for a wide range of applications. The Group's strategy is to target commercial applications in three core markets: coatings, composites and functional materials.

The Group has developed proprietary bottom-up processes which are capable of producing high purity graphene nanoplatelets using a continuous process. The manufacturing process is based on sustainable, readily available raw materials and therefore does not rely on the supply of graphite, unlike a number of other graphene production techniques. Applied Graphene Materials owns the intellectual property and know-how behind this process.

Applied Graphene Materials was founded by Professor Karl Coleman in 2010 with its operations and processes based on technology that he initially developed at Durham University. The Group was admitted to AIM in November 2013, raising £11 million, and is based at the Wilton Site on Teesside. In January 2016 the Group raised £8.5m to support its ongoing activities and in October 2017 the Group raised a further £9.8m. https://www.appliedgraphenematerials.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKBBQBBKDFFD

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.